In accordance with the relevant requirements in the Guidelines for the Disclosure of Government Information on Environmental Impact Assessment of Construction Projects (Trial), the relevant information on environmental impact assessment of the project is publicized as follows:
1, Project name: Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., LTD. New production of oseltamivir phosphate granules, celecoxib capsule product construction project;
2. Location: No. 16, Life Garden Road, Changping District, Beijing;
3. Construction unit: Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., LTD.
Contact person: Li Fang Tel: 17600503444;
4. Environmental Impact Assessment Agency: Zhonghuan Lianxin (Beijing) Environmental Protection Co., LTD.
Contact: Zhao Guobin 18518292330;
Email: 574339687@qq.com;
5, the eia report (copy) link: https://pan.baidu.com/s/1012LzIWBx6p_vKfQ0pwYSA
Extraction code: 849g.
6, the way of public comments: telephone, E-mail, fax, etc. The public sheet download link: http://www.mee.gov.cn/xxgk2018/xxgk/xxgk01/201810/t20181024_665329.html, the public are free to download.
Home